文献速递术前评估与围术期医学

镁对深肌松罗库溴铵剂量的影响:随机对照试验

Effects of magnesium on the dose of rocuronium for deep neuromuscular blockade: A randomised controlled trial.
PubMed 文献 · Eur J Anaesthesiol · 2021-01-01

结果显示镁组罗库溴铵维持剂量显著低于对照组(7.5 vs. 9.4 μg kg-1 min-1,P = 0.01),恢复时间及术后恶心呕吐发生率无差异。结论为镁剂可使深肌松所需罗库溴铵剂量减少约20%,且不影响舒更葡糖拮抗后的恢复时间。

要点

  • 镁剂可使深肌松维持所需罗库溴铵剂量减少约20%。
  • 镁组罗库溴铵剂量7.5 vs. 对照组9.4 μg kg-1 min-1,P = 0.01。
  • 两组恢复时间及术后恶心呕吐发生率无差异。

核心结论

  • 镁剂可使深肌松所需罗库溴铵剂量减少约20%,且不影响舒更葡糖给药后的恢复时间。

主要发现

  • 维持深肌松的罗库溴铵剂量镁组显著低于对照组(7.5 vs. 9.4 μg kg-1 min-1,P = 0.01)。
  • 恢复时间(舒更葡糖给药至四个成串刺激比值0.9的时间)及术后恶心呕吐发生率两组无差异。

关键数值与推荐

  • 镁组:先给予50 mg kg-1镁剂,术中持续输注15 mg kg-1 h-1;对照组输注等容量0.9%生理盐水。
  • 深肌松用罗库溴铵持续输注维持,并用舒更葡糖拮抗。

临床怎么用

  • 在需深肌松且使用镁剂的患者中,可预期罗库溴铵维持剂量降低,需据此调整输注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Magnesium is known to enhance the effect of rocuronium, but the extent is not quantified. OBJECTIVES: We aimed to quantify the effect of magnesium on the dose of rocuronium for deep neuromuscular blockade. DESIGN: A randomised controlled study. SETTING: A single tertiary care hospital. PATIENTS: Seventy males scheduled to undergo robot-assisted laparoscopic prostatectomy, aged between 20 and 80 years with American Society of Anesthesiologists physical status classification 1 or 2, were enrolled. INTERVENTIONS: Patients were randomised to either the magnesium group or control group. The magnesium group were infused with 50 mg kg-1 of magnesium, followed by a continuous intra-operative infusion at 15 mg kg-1 h-1 while the control group were infused with the same volumes of 0.9% saline. Deep neuromuscular blockade was maintained with a continuous infusion of rocuronium and was reversed using sugammadex. MAIN OUTCOME MEASURES: The primary outcome was the dose of rocuronium administered to maintain deep neuromuscular blockade. The secondary outcomes were recovery time, defined as the time from the administration of sugammadex to train-of-four ratio 0.9, and the incidence of postoperative nausea and vomiting. RESULTS: The dose of rocuronium administered to maintain deep neuromuscular blockade was significantly lower in the magnesium group (7.5 vs. 9.4 μg kg-1 min-1, P = 0.01). There was no difference in recovery time or the incidence of nausea and vomiting. CONCLUSION: Magnesium reduced the dose of rocuronium required for deep neuromuscular blockade by approximately 20% without affecting the recovery time after administration of sugammadex. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT04013243.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Han J, Jeon YT, Ryu JH, et al. Effects of magnesium on the dose of rocuronium for deep neuromuscular blockade: A randomised controlled trial. Eur J Anaesthesiol. 2021. PMID: 32890015. doi:10.1097/EJA.0000000000001329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。